dyslipidemia vs dyslipidaemia

Both "dyslipidemia" and "dyslipidaemia" are correct spellings of the medical term referring to abnormal levels of lipids in the blood. The spelling with 'emia' is more common in American English, while the spelling with 'aemia' is more common in British English. Both spellings are widely accepted and used in medical literature.

Last updated: March 27, 2024 • 971 views

dyslipidemia

This is a correct spelling of the medical term referring to abnormal levels of lipids in the blood. It is commonly used in American English.

This term is used to describe a condition characterized by abnormal levels of lipids (cholesterol and triglycerides) in the blood. It is commonly seen in medical contexts.

Examples:

The patient was diagnosed with dyslipidemia and prescribed medication to manage cholesterol levels.
Regular exercise and a healthy diet can help in the management of dyslipidemia.
Dyslipidemia is a risk factor for cardiovascular diseases.
The doctor recommended a lipid profile test to check for dyslipidemia.
Treatment for dyslipidemia may include statin medications.

Show examples from the web [+]

Patients had a BMI >= 30 kg/ m² or BMI > 27 kg/ m² with hypertension and/ or dyslipidemia at inclusion.
This is accompanied by an increase in disorders such as high blood pressure, obesity and dyslipidemia, as well as smoking-related disorders.
Treatment of dyslipidemia Mixed dyslipidaemia characterised by hypertriglyceridaemia and/ or low HDL-cholesterol.
Consultation with standard guidelines for management of dyslipidaemia is recommended.
Mixed dyslipidaemia characterised by hypertriglyceridaemia and/ or low HDL-cholesterol.
Hypercholesterolemia still is an indication, but mainly in combination with such dyslipidaemia.
Pelzont was studied in four main studies in patients with hypercholesterolaemia or mixed dyslipidaemia.
Experience in pediatrics is limited to a small number of patients (age 4 - 17 years) with severe dyslipidemias, such as homozygous familial hypercholesterolemia.
In clinical studies, REYATAZ (with or without ritonavir) has been shown to induce dyslipidaemia to a lesser extent than comparators.
Weight loss induced by< Invented name > is accompanied by beneficial changes in serum lipids and glycaemic control in patients with dyslipidaemia and type 2 diabetes, respectively.
Treatment of primary hypercholesterolaemia or mixed dyslipidaemia, treatment of homozygous familial hypercholesterolaemia.
Combination antiretroviral therapy (CART), including REYATAZ (with or without ritonavir)-based CART, is associated with dyslipidaemia.
Crestor (rosuvastatin calcium) is a selective 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor (statin) that has been approved for use as a lipid-regulating agent in the management of patients with dyslipidaemia.
Lipid alterations should be managed as clinically appropriate, particularly in dyslipidemic patients and in patients with risk factors for the development of lipids disorders.
Pelzont is used in addition to diet and exercise in patients with dyslipidaemia (abnormally high levels of fat in the blood), particularly' combined mixed dyslipidaemia' and' primary hypercholesterolaemia'.
The Committee for Medicinal Products for Human Use (CHMP) decided that Pelzont's benefits are greater than its risks for the treatment of dyslipidaemia, particularly in patients with combined mixed dyslipidaemia and in patients with primary hypercholesterolaemia.
Pelzont is indicated for the treatment of dyslipidaemia, particularly in patients with combined mixed dyslipidaemia (characterised by elevated levels of LDL-cholesterol and triglycerides and low HDL-cholesterol) and in patients with primary hypercholesterolaemia (heterozygous familial and non-familial).
Tredaptive is used in addition to diet and exercise in patients with dyslipidaemia (abnormally high levels of fat in the blood), particularly' combined mixed dyslipidaemia' and' primary hypercholesterolaemia'.
Similarly, in obese patients with dylipidaemia, weight loss was associated with increases in HDL choleseterol of 12-22% and reductions in triglycerides of 9-21%.
Patients with combined mixed dyslipidaemia have high blood levels of' bad' LDL cholesterol and triglycerides (a type of fat), and low levels of' good' HDL cholesterol.

Alternatives:

hyperlipidemia
lipid disorder
abnormal lipid levels
high cholesterol
elevated triglycerides

dyslipidaemia

This is a correct spelling of the medical term referring to abnormal levels of lipids in the blood. It is commonly used in British English.